Nombre del producto:3-(8-Chloro-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl)cyclobutanone

IUPAC Name:3-[8-chloro-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl]cyclobutan-1-one

CAS:867165-62-6
Fórmula molecular:C25H17ClN4O
Pureza:95%+
Número de catálogo:CM330050
Peso molecular:424.88

Unidad de embalaje Stock disponible Precio($) Cantidad
CM330050-100mg 1-2 Weeks Ÿƴȅƚ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :867165-62-6
Fórmula molecular:C25H17ClN4O
Punto de fusión:-
Código de sonrisas:O=C1CC(C1)C2=NC(C3=CC=C4C(N=C(C5=CC=CC=C5)C=C4)=C3)=C6N2C=CN=C6Cl
Densidad:
Número de catálogo:CM330050
Peso molecular:424.88
Punto de ebullición:
Nº Mdl:
Almacenamiento:-20°C

Category Infos

Quinolines
Quinolines are an important class of biologically active heterocyclic compounds, and their derivatives usually exhibit a variety of biological activities. They can be used as antimalarial drugs and in the preparation of other antimalarial drugs. Other important activities of quinoline derivatives include inhibitory activity against EGFR-TK and antipsychotic activity. Futhermore, quinoline scaffolds are present in various drug molecules, including the antimalarial drugs aablaquine, chloroquine, mefloquine and primaquine, and the antibacterial agents gatifloxacin, levofloxacin, and moxifloxacin.
Quinoline Price
if you have any question on quinoline price, we will give the professional answers to your short questions.
Cyclobutanes
The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.
Imidazopyrazines
In addition to the nitrogen-based heterocycles presented so far, a number of others nitrogen-based scaffolds have also been reported as promising agents for GBM treatment, including pyrazolo-triazole, imidazotetrazine, piperidine, purine, imidazopyrazine, pyrazole, triazole among others.